Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

576
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
576
Humoral Immune Responses01:36

Humoral Immune Responses

84.1K
Overview
84.1K
Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

490
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
490
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

333
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
333
Complement System01:27

Complement System

10.9K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
10.9K
Complementation Tests00:49

Complementation Tests

6.3K
A complementation test is a simple cross to identify whether the two mutations are located on the same gene or different genes. It was first performed by Edward Lewis in the 1940s while working on fruit flies. He developed the test to identify the location and arrangement of different mutations on chromosomes.
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A new perspective on AMD pathogenesis: a sequential Factor H-centered view of complement dysregulation.

Frontiers in immunology·2026
Same author

Nanotube vesicles: a new neutrophil inflammatory response.

Blood·2026
Same author

Deletion of the Mouse Homolog of Human FHR1 (muFHR1) Alleviates Atherosclerosis in ApoE-/- mice.

International journal of medical sciences·2026
Same author

Combined FXIII-C3 autoantibodies elicit bleeding and complement dysfunction in autoimmune FXIII deficiency.

The Journal of clinical investigation·2025
Same author

Optimized Cell-Based Platform for Platelet-Free Detection of Heparin-Induced Thrombocytopenia Antibodies.

Advanced biology·2025
Same author

Factor-H-related protein 1 (FHR1), a promotor of para-inflammation in age-related macular degeneration.

Journal of neuroinflammation·2025

Related Experiment Video

Updated: Feb 11, 2026

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion
06:54

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion

Published on: June 15, 2019

6.4K

Complement factor H related proteins in immune diseases.

Christine Skerka1, Peter F Zipfel

  • 1Department of Infection Biology, Leibniz Institute for Natural Product Research and Infection Biology, Jena, Germany. christine.skerka@hki-jena.de

Vaccine
|April 24, 2009
PubMed
Summary

Complement factor H-related proteins (CFHR) are linked to autoimmune diseases. Deletions in CFHR1/CFHR3 genes increase risk for hemolytic uremic syndrome (HUS) but protect against age-related macular degeneration (AMD).

More Related Videos

Dissecting Multi-protein Signaling Complexes by Bimolecular Complementation Affinity Purification BiCAP
06:45

Dissecting Multi-protein Signaling Complexes by Bimolecular Complementation Affinity Purification BiCAP

Published on: June 15, 2018

8.0K
Genome-wide Protein-protein Interaction Screening by Protein-fragment Complementation Assay PCA in Living Cells
08:38

Genome-wide Protein-protein Interaction Screening by Protein-fragment Complementation Assay PCA in Living Cells

Published on: March 3, 2015

13.9K

Related Experiment Videos

Last Updated: Feb 11, 2026

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion
06:54

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion

Published on: June 15, 2019

6.4K
Dissecting Multi-protein Signaling Complexes by Bimolecular Complementation Affinity Purification BiCAP
06:45

Dissecting Multi-protein Signaling Complexes by Bimolecular Complementation Affinity Purification BiCAP

Published on: June 15, 2018

8.0K
Genome-wide Protein-protein Interaction Screening by Protein-fragment Complementation Assay PCA in Living Cells
08:38

Genome-wide Protein-protein Interaction Screening by Protein-fragment Complementation Assay PCA in Living Cells

Published on: March 3, 2015

13.9K

Area of Science:

  • Immunology
  • Genetics

Background:

  • The complement system is crucial for innate immunity, eliminating pathogens and altered self-cells.
  • Tight regulation of complement is essential to prevent host tissue damage and autoimmune diseases.
  • Imbalances in complement regulation are implicated in conditions like hemolytic uremic syndrome (HUS) and age-related macular degeneration (AMD).

Purpose of the Study:

  • To summarize current knowledge on the role of complement factor H-related proteins 1 and 3 (CFHR1 and CFHR3) in HUS and AMD.
  • To explore the association of CFHR1 and CFHR3 with specific human diseases.

Main Methods:

  • Review of existing literature on complement system regulation and associated genetic factors.
  • Analysis of disease-associated mutations and chromosomal deletions within the factor H protein family genes.

Main Results:

  • Homozygous deletion of the CFHR1/CFHR3 genes is a risk factor for early-onset HUS, often linked to autoantibodies against complement factor H (CFH).
  • This deletion confers protection against the development of AMD in older individuals.
  • CFHR1 and CFHR3 proteins, and potentially other CFHR family members, are implicated in human disease pathogenesis.

Conclusions:

  • CFHR1 and CFHR3 play significant, contrasting roles in HUS and AMD.
  • Understanding the function of CFHR proteins is critical for comprehending the mechanisms underlying these diseases.